Literature DB >> 12472534

Clinical, histopathological and immunological distinction in two cases of IgA pemphigus.

T Hashimoto1, S Yasumoto, Y Nagata, T Okamoto, S Fujita.   

Abstract

Two cases of IgA pemphigus, one of the subcorneal pustular dermatosis (SPD) type and one of the intraepidermal neutrophilic IgA dermatosis (IEN) type, are described. IgA anti-keratinocyte cell surface antibodies reacted only with the uppermost epidermis in the SPD type but with the entire epidermis in the IEN type. A cDNA transfection test for desmocollins (Dsc) revealed that IgA antibodies of the SPD type reacted with Dsc1, but the IEN type did not react with any of the Dsc isoforms (Dsc1-3). ELISA for desmoglein 1 (Dsg1) and Dsg3 showed that neither of the cases had antibodies to Dsg - of either the IgG or IgA subtype. These results confirm that the autoantigen in SPD-type IgA pemphigus is Dsc1, whereas the antigen in most cases of IEN-type IgA pemphigus is unknown.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12472534     DOI: 10.1046/j.1365-2230.2002.01061.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  4 in total

Review 1.  Autoinflammatory pustular neutrophilic diseases.

Authors:  Haley B Naik; Edward W Cowen
Journal:  Dermatol Clin       Date:  2013-06-02       Impact factor: 3.478

Review 2.  Molecular diagnosis in autoimmune skin blistering conditions.

Authors:  J V Otten; T Hashimoto; M Hertl; A S Payne; C Sitaru
Journal:  Curr Mol Med       Date:  2014-01       Impact factor: 2.222

3.  Imatinib-induced IgA Pemphigus: Subcorneal Pustular Dermatosis Type.

Authors:  Aradhana Sood; Preema Sinha; Deep K Raman; Anwita Sinha
Journal:  Indian Dermatol Online J       Date:  2018 Sep-Oct

4.  Anti-Desmocollin Autoantibodies in Autoimmune Blistering Diseases.

Authors:  Xavier Bosch-Amate; Pilar Iranzo; Marta Ivars; José Manuel Mascaró Galy; Agustín España
Journal:  Front Immunol       Date:  2021-09-10       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.